![](/images/graphics-bg.png)
Efficacy of influenza vaccination in patients with cirrhosis and inactive carriers of hepatitis B virus infection
المؤلفون المشاركون
Alavian, S. M.
Behnava, B.
Sayyad, B.
Najafi, F.
Azad, T. Mokhtari
Tabarestani, M. H. Ari
Shirvani, M.
Afshrian, M.
Vaziri, S.
Janbakhsh, A. R.
Mansuri, F.
Kaviani, Sh.
المصدر
Iranian Red Crescent Medical Journal
العدد
المجلد 14، العدد 10 (31 أكتوبر/تشرين الأول 2012)8ص.
الناشر
تاريخ النشر
2012-10-31
دولة النشر
الإمارات العربية المتحدة
عدد الصفحات
8
التخصصات الرئيسية
الموضوعات
الملخص EN
Background : Influenza can causes morbidity and mortality that are greatly enhanced in patients with underlying chronic diseases such as Cirrhotic patients.
This study was performed to assess the immunogenicity of Influenza vaccination in patients with cirrhosis and inactive carriers of Hepatitis B virus infection. Methods : In this clinical study 93 enrolled subjects divided into 3 groups : Cirrhotic (N = 28), Inactive carriers of Hepatitis B (N = 31) and subjects (N = 34).
All the participants were vaccinated by Influenza vaccine (Influvac®).
Serum samples were taken before and 4 weeks after vaccination and the Humoral Immunogenicity was assessed by the Hemagglutination iInhibition (HI) test. Results : Four weeks after vaccination, seroconversion rates of vaccine strains ranged between 71.4 % and 100 % in Group 1, 70.6 % and 94.1 % in Group 2, and 58.1 % and 80.7 % in Group 3.
No significant differences were seen in the rates of Seroconversion and antibody Geometric Mean Titers (GMTs) against Influenza A (H1N1 and H3N2) vaccine components in the three groups (P > 0.05).The rates of Seroconversion and antibody GMTs against Influenza B vaccine component were significantly higher in Cirrhotic and inactive carriers of Hepatitis B than healthy subjects (P < 0.005).
No significant (P > 0.05) differences in the rates of Seroprotection were observed within the three groups.
Antibody GMTs against all three strains of Influenza vaccine increased significantly (P < 0.001) after vaccination in three groups. Conclusion : Influenza vaccination is effective in Cirrhotic patients and inactive carriers of Hepatitis B as well as healthy individuals.
It means that vaccination should be considered in such patients in order to reduce the morbidity and mortality of Influenza.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Sayyad, B.& Alavian, S. M.& Najafi, F.& Azad, T. Mokhtari& Tabarestani, M. H. Ari& Shirvani, M.…[et al.]. 2012. Efficacy of influenza vaccination in patients with cirrhosis and inactive carriers of hepatitis B virus infection. Iranian Red Crescent Medical Journal،Vol. 14, no. 10.
https://search.emarefa.net/detail/BIM-310993
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Sayyad, B.…[et al.]. Efficacy of influenza vaccination in patients with cirrhosis and inactive carriers of hepatitis B virus infection. Iranian Red Crescent Medical Journal Vol. 14, no. 10 (Oct. 2012).
https://search.emarefa.net/detail/BIM-310993
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Sayyad, B.& Alavian, S. M.& Najafi, F.& Azad, T. Mokhtari& Tabarestani, M. H. Ari& Shirvani, M.…[et al.]. Efficacy of influenza vaccination in patients with cirrhosis and inactive carriers of hepatitis B virus infection. Iranian Red Crescent Medical Journal. 2012. Vol. 14, no. 10.
https://search.emarefa.net/detail/BIM-310993
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references.
رقم السجل
BIM-310993
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)